FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology. Method of treating cutaneous wound in a subject, including a diabetic, is described, comprising administering to the subject a compound that inhibits the VEGF-B signaling pathway.
EFFECT: invention expands the arsenal of wound healing.
19 cl, 7 dwg, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING NEPHROPATHY | 2014 |
|
RU2718054C2 |
| METHOD FOR TREATMENT OR PREVENTION OF STROKE | 2015 |
|
RU2744909C2 |
| LOX1-SPECIFIC BINDING PROTEINS AND THEIR APPLICATION METHODS | 2015 |
|
RU2764993C2 |
| OPTIMIZED OPTIONS OF ANTI-VEGF ANTIBODIES | 2016 |
|
RU2763916C2 |
| COMPOSITIONS AND METHODS FOR SUPPRESSION OF CANCER STEM CELLS | 2016 |
|
RU2752610C1 |
| CHIMERIC AND HUMANISED INTEGRIN α5β1 ANTIBODIES MODULATING ANGIOGENESIS | 2003 |
|
RU2346701C2 |
| EXPRESSION AND SECRETION SYSTEM | 2013 |
|
RU2670491C2 |
| ANTIBODIES TO INTERLEUKIN-6 AND USES THEREOF | 2013 |
|
RU2656162C2 |
| ANTI-BV8 ANTIBODIES AND USING THEM | 2010 |
|
RU2559542C2 |
| ANTIBODY THAT BINDS TO VEGF AND IL-1BETA, AND METHODS OF USE THEREOF | 2019 |
|
RU2816476C2 |
